Agency Forms Undergoing Paperwork Reduction Act Review, 34016-34017 [E7-11934]
Download as PDF
34016
Federal Register / Vol. 72, No. 118 / Wednesday, June 20, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given that
the Office of Research Integrity (ORI)
and the Assistant Secretary for Health
have taken final action in the following
case:
Carlos A. Murillo, M.D., University of
Texas Medical Branch at Galveston:
Based on the report of an inquiry
conducted by the University of Texas
Medical Branch at Galveston (UTMB)
and additional analysis and information
obtained by the Office of Research
Integrity during its oversight review, the
U.S. Public Health Service (PHS) found
that Carlos A. Murillo, M.D., former
Surgical Resident, Department of
Surgery, UTMB, engaged in research
misconduct in research supported by
National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK),
National Institutes of Health (NIH),
grants R01 DK48498 and T32 DK07639.
Specifically, Dr. Murillo falsified
research on the amelioration by
antisense RNA (siRNA) of dextraninduced colonic toxicity in mice. He
altered the concentrations of dextran
solution fed to mice to induce colonic
inflammation, by intentionally
including little or no dextran in the
drinking water of siRNA treated mice,
so that the animals that received siRNA
would have few or no colonic lesions.
Dr. Murillo has entered into a
Voluntary Exclusion Agreement
(Agreement) in which he has voluntarily
agreed, for a period of three (3) years,
beginning on May 30, 2007:
(1) That any institution that submits
an application for PHS support for a
research project on which Dr. Murillo’s
participation is proposed or that uses
him in any capacity on PHS support
research, or that submits a report of
PHS-funded research in which he is
involved, must concurrently submit a
plan for supervision of his duties to the
funding agency for approval; the
supervisory plan must be designed to
ensure the scientific integrity of Dr.
Murillo’s research contribution; Dr.
Murillo agrees to ensure that a copy of
the supervisory plan is also submitted to
ORI by the institution and agrees that he
will not participate in any PHSsupported research until such a
supervision plan is submitted to ORI;
(2) to exclude himself from serving in
any advisory capacity to PHS, including
but not limited to service on any PHS
advisory committee, board, and/or peer
review committee, or as a consultant;
and
(3) to request retraction of the abstract
entitled ‘‘Inhibition of Phosphoinositol
3-kinase Using Anti-p85 siRNA
Attenuates Dextran-Sulfate-Induced
Inflammatory Bowel Disease’’
(Gastroenterology 126:A49, 2004), by
signing the letter of retraction prepared
by ORI attached as Attachment 2 and
made part of the Agreement.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
John Dahlberg,
Acting Director,Office of Research Integrity.
[FR Doc. E7–11908 Filed 6–19–07; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day-07–06BF]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
Proposed Project
Assessment and Evaluation of the
Role of Care Coordination (Case
Management) in Improving Access and
Care within the Spina Bifida Clinic
System—New—National Center for
Birth Defects and Developmental
Disabilities (NCBDDD), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a one-year approval
from the Office of Management and
Budget to collect information about the
effectiveness of care coordination for
patients with spina bifida. Studies have
shown that care coordination is
beneficial for individuals with complex
health conditions such as cystic fibrosis
and sickle cell anemia, however, the
extent to which care coordination is
effective for assisting individuals with
spina bifida is unknown. Spina bifida is
one of the most common birth defects,
affecting approximately 3 per 10,000
live births in the United States annually.
The proposed activity is part of the
National Spina Bifida Program
mandated in Section 317C of the Public
Health Service Act (42 U.S.C. 247b–4).
Researchers will visit 10 spina bifida
clinics nationwide. At each clinic, one
focus group will be conducted with
approximately eight caregivers of
children with spina bifida. Each focus
group will last about two hours. In
addition, interviews will be conducted
with approximately five staff members
at each clinic; each interview will take
approximately 45 minutes. Focus group
and interview respondents will be asked
a variety of questions related to care
coordination for individuals with spina
bifida including how care is coordinated
in the clinic, barriers and facilitators to
the provision of care coordination, the
effectiveness of care coordination, and
recommendations for improving care
coordination.
There will be no costs to the
respondents other than their time. The
total estimated annualized burden hours
are 244.
Estimated Annualized Burden Hours:
Number of
respondents
Type of respondents
rwilkins on PROD1PC63 with NOTICES
comments should be received within 30
days of this notice.
Form name
Caregivers for Spina Bifida Patients ...............
Focus Group Response Form .......................
Focus Group Telephone Script ......................
Focus Group Moderator’s Guide ...................
Clinic Recruitment Script ................................
Clinic Staff Telephone Interview Script ..........
Spina Bifida Clinic Staff ..................................
VerDate Aug<31>2005
18:25 Jun 19, 2007
Jkt 211001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
E:\FR\FM\20JNN1.SGM
100
100
80
14
55
20JNN1
Number of
reponses per
respondent
1
1
1
1
1
Average
burden per
response
(in hours)
5/60
15/60
2
15/60
10/60
34017
Federal Register / Vol. 72, No. 118 / Wednesday, June 20, 2007 / Notices
Type of respondents
Number of
respondents
Form name
Clinic Staff Interview Guide ............................
Dated: June 14, 2007.
Catina Conner,
Acting Assistant Reports Clearance
Officer,Centers for Disease Control and
Prevention.
[FR Doc. E7–11934 Filed 6–19–07; 8:45 am]
Measurement—New—Agency for Toxic
Substances and Disease Registry
(ATSDR), Centers for Disease Control
and Prevention (CDC).
BILLING CODE 4163–18–P
ATSDR considers evaluation to be a
critical component for enhancing
program effectiveness and improving
resource management. ATSDR’s
mandate under the Comprehensive
Environmental Response,
Compensation, and Liability Act
(CERLCA), as amended, is to help
prevent or reduce further exposures at
hazardous waste sites and the illnesses
that result from such exposures. A
standardized methodology to monitor
outcomes associated with agency
intervention will provide the data
needed for demonstrating effectiveness
and efficiency as well as identifying
areas for improvement.
ATSDR, in cooperation with our
cooperative agreement partners, is
developing a series of survey modules
designed to measure individual
attitudes, knowledge and behaviors, as
well as mental and physical health selfassessments, that may be influenced by
health education and health promotion
efforts conducted by the agency at
hazardous waste sites. These modules
will be used to determine knowledge
improvements, attitude shifts, and
behavior change following specific
ATSDR program efforts and activities.
The particular module or combination
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–07–05AT]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–4604 or send an
e-mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
comments should be received within 30
days of this notice.
Proposed Project
A Site Specific Modular Evaluation
Instrument for Behavior Outcome
Background and Brief Description
Number of
sites
Type of respondents
rwilkins on PROD1PC63 with NOTICES
General Public at Existing Sites with Exposed Populations of 10,000 or
Less ..............................................................................................................
General Public at Existing Sites with New Interventions or New Sites with
Exposed Populations of 10,000 or Less ......................................................
General Public at Existing Sites with Exposed Populations of 10,000 or
More .............................................................................................................
General Public at Existing Sites with New Interventions or New Sites with
Exposed Populations of 10,000 or More .....................................................
VerDate Aug<31>2005
18:25 Jun 19, 2007
Jkt 211001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
50
Number of
reponses per
respondent
1
Average
burden per
response
(in hours)
45/60
of modules(s) used at a site will vary
depending on the contaminant(s) of
concern and education/health
promotion actions undertaken. In
addition, the timing of the data
collection will vary depending on
whether this is a new site or one that
has been underway for some time. In
general, for new sites or existing sites
with new intervention efforts, we would
aim for two data collections, baseline
and post-intervention. At existing sites
where ATSDR interventions have been
completed, we would collect data once,
post-intervention.
Health education and promotion
activities are conducted at
approximately 250 sites annually. We
estimate that 90% will have total
exposed or potentially exposed
populations of 10,000 or less, and we
expect to survey up to 150 respondents
at each site. At sites with exposed or
potentially exposed populations of more
than 10,000, we expect to survey up to
500 respondents at each site.
Using a standardized methodology
and survey instrument to assess
outcomes related to targeted
intervention activities at hazardous
waste sites will provide the agency with
important feedback for program
improvement. There will be no costs to
respondents except for their time to
participate in the survey. The total
estimated annualized burden hours are
27,250.
Estimated Annualized Burden Hours:
Number of
respondents
Number of responses
per respondent
Average
burden per
response
(in hours)
55
150
1
20/60
170
150
2
20/60
5
500
1
20/60
20
500
2
20/60
E:\FR\FM\20JNN1.SGM
20JNN1
Agencies
[Federal Register Volume 72, Number 118 (Wednesday, June 20, 2007)]
[Notices]
[Pages 34016-34017]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-07-06BF]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of
Management and Budget, Washington, DC or by fax to (202) 395-6974.
Written comments should be received within 30 days of this notice.
Proposed Project
Assessment and Evaluation of the Role of Care Coordination (Case
Management) in Improving Access and Care within the Spina Bifida Clinic
System--New--National Center for Birth Defects and Developmental
Disabilities (NCBDDD), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
CDC is requesting a one-year approval from the Office of Management
and Budget to collect information about the effectiveness of care
coordination for patients with spina bifida. Studies have shown that
care coordination is beneficial for individuals with complex health
conditions such as cystic fibrosis and sickle cell anemia, however, the
extent to which care coordination is effective for assisting
individuals with spina bifida is unknown. Spina bifida is one of the
most common birth defects, affecting approximately 3 per 10,000 live
births in the United States annually. The proposed activity is part of
the National Spina Bifida Program mandated in Section 317C of the
Public Health Service Act (42 U.S.C. 247b-4).
Researchers will visit 10 spina bifida clinics nationwide. At each
clinic, one focus group will be conducted with approximately eight
caregivers of children with spina bifida. Each focus group will last
about two hours. In addition, interviews will be conducted with
approximately five staff members at each clinic; each interview will
take approximately 45 minutes. Focus group and interview respondents
will be asked a variety of questions related to care coordination for
individuals with spina bifida including how care is coordinated in the
clinic, barriers and facilitators to the provision of care
coordination, the effectiveness of care coordination, and
recommendations for improving care coordination.
There will be no costs to the respondents other than their time.
The total estimated annualized burden hours are 244.
Estimated Annualized Burden Hours:
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents reponses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Caregivers for Spina Bifida Patients.. Focus Group Response 100 1 5/60
Form.
Focus Group Telephone 100 1 15/60
Script.
Focus Group Moderator's 80 1 2
Guide.
Spina Bifida Clinic Staff............. Clinic Recruitment 14 1 15/60
Script.
Clinic Staff Telephone 55 1 10/60
Interview Script.
[[Page 34017]]
Clinic Staff Interview 50 1 45/60
Guide.
----------------------------------------------------------------------------------------------------------------
Dated: June 14, 2007.
Catina Conner,
Acting Assistant Reports Clearance Officer,Centers for Disease Control
and Prevention.
[FR Doc. E7-11934 Filed 6-19-07; 8:45 am]
BILLING CODE 4163-18-P